Oxford Asset Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $281K | Sell |
127,175
-134,155
| -51% | -$296K | 0.04% | 94 |
|
|
2019
Q4 | $797K | Sell |
261,330
-48,016
| -16% | -$146K | 0.02% | 996 |
|
|
2019
Q3 | $951K | Buy |
309,346
+95,575
| +45% | +$294K | 0.02% | 969 |
|
|
2019
Q2 | $428K | Buy |
213,771
+89,308
| +72% | +$179K | 0.01% | 1329 |
|
|
2019
Q1 | $536K | Sell |
124,463
-48,631
| -28% | -$209K | 0.01% | 1185 |
|
|
2018
Q4 | $550K | Sell |
173,094
-36,940
| -18% | -$117K | 0.01% | 1155 |
|
|
2018
Q3 | $1.1M | Buy |
210,034
+44,936
| +27% | +$234K | 0.02% | 964 |
|
|
2018
Q2 | $876K | Buy |
165,098
+108,190
| +190% | +$574K | 0.02% | 1106 |
|
|
2018
Q1 | $285K | Buy |
+56,908
| New | +$285K | 0.01% | 1413 |
|
|
2016
Q3 | – | Sell |
-12,392
| Closed | -$35K | – | 804 |
|
|
2016
Q2 | $35K | Buy |
+12,392
| New | +$35K | ﹤0.01% | 765 |
|